Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action

Open Access

Peer-reviewed

Research Article

Chang Ji Zheng,

Affiliation Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejeon, Republic of Korea
⨯
Mi-Jin Sohn,

Affiliation Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejeon, Republic of Korea
⨯
Sangku Lee,

Affiliation Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejeon, Republic of Korea
⨯
Won-Gon Kim

* E-mail: wgkim@kribb.re.kr

Affiliation Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejeon, Republic of Korea
⨯

Reader Comments (0)

Staphylococcus aureus
Is the Subject Area "Staphylococcus aureus" applicable to this article?

Thanks for your feedback.
Antibacterials
Is the Subject Area "Antibacterials" applicable to this article?

Thanks for your feedback.
Pneumococcus
Is the Subject Area "Pneumococcus" applicable to this article?

Thanks for your feedback.
Fatty acids
Is the Subject Area "Fatty acids" applicable to this article?

Thanks for your feedback.
Protein synthesis
Is the Subject Area "Protein synthesis" applicable to this article?

Thanks for your feedback.
Antibiotics
Is the Subject Area "Antibiotics" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Methicillin-resistant Staphylococcus aureus
Is the Subject Area "Methicillin-resistant Staphylococcus aureus" applicable to this article?

Thanks for your feedback.